Acabrunat
Brand Name: Acabrunat®
Composition: Acalabrutinib Capsules 100 mg
Quantity: 30 Capsules
Manufacturer: NATCO
Product Description
Medical Info
Acabrunat® is a high-quality pharmaceutical formulation containing Acalabrutinib (100 mg), manufactured by NATCO. As a highly selective, small-molecule Bruton’s tyrosine kinase (BTK) inhibitor, it is primarily indicated for targeted oncology treatment, particularly in managing specific hematological malignancies such as chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). Each pack contains 30 capsules engineered to safely deliver precise therapeutic dosing. By blocking signals that stimulate malignant B-cells to grow and divide, Acabrunat® provides a vital therapeutic pathway in modern oncology, offering clinicians a reliable option for enhancing patient care and managing specialized disease progression.
Storage & Safety
Precautions & Warnings
Reconstitute only with the prescribed quantity of clean drinking water. Shake well before each use. Complete the full course as prescribed. Discard any unused suspension after 7 days of reconstitution.
Storage
Store in a cool, dry place below 25°C. Protect from light and moisture. Refrigeration after reconstitution is preferred.
Status
Keep all medicines out of reach of children.
